Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global Metabolomics Market was valued at USD 1.15 billion in 2016 and is projected to reach USD 3.91billion by 2025, growing at a CAGR of 14.54% from 2017 to 2025.
Metabolomics is the scientific study of chemical processes involving metabolites. Specifically, metabolomics is the systematic study of the unique chemical fingerprints that specific cellular processes leave behind,
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Availability of Government and Private Funding
1.2 Increasing Pharmaceutical and Biotech R&D Expenditure
1.3 Technological Advancements
1.4 Growing Demand for Personalized Medicine
1.5 Increasing Use of Metabolomics in Toxicology Testing
2. Market Restraints
2.1 Issues Related to Data Examination and Processing
2.2 High Cost of equipment
Market Segmentation:
1. Global MetabolomicsMarket, by Indication:
1.1 Cancer
1.2 Cardiovascular Disorders
1.3 Neurological Disorders
1.4 Inborn Errors of Metabolism
1.5 Other Indications
2. Global MetabolomicsMarket, by Application:
2.1 Biomarker Discovery
2.2 Drug Discovery
2.3 Toxicology Testing
2.4 Nutrigenomics
2.5 Functional Genomics
2.6 Personalized Medicine
2.7 Other Applications
3. Global MetabolomicsMarket, by Product and Services:
3.1 Metabolomics Instruments
3.1.1 Separation Tools
3.1.1.1 High-Performance Liquid Chromatography
3.1.1.2 Gas Chromatography
3.1.1.3 Ultra-Performance Liquid Chromatography
3.1.1.4 Capillary Electrophoresis
3.1.2 Detection Tools
3.1.2.1 Mass Spectrometry
3.1.2.2 Nuclear Magnetic Resonance Spectroscopy
3.1.2.3 Surface-Based Mass Analysis
3.2 Metabolomics Bioinformatics tools and services
3.2.1 Bioinformatics Tools & Databases
3.2.2 Bioinformatics Services
4. Global Metabolomics Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific Inc.
2. Agilent Technologies, Inc.
3. Waters Corporation
4. Danaher Corporation
5. Shimadzu Corporation
6. Biocrates Life Sciences AG
7. Bio-Rad Laboratories, Inc.
8. Bruker Corporation
9. Human Metabolome Technologies, Inc.
10. Leco Corporation
11. Metabolon, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the MetabolomicsMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.